AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32912274 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg elacestrant QD (escalated to 400 mg after 14 days)
Number of subjects: 16
Study 32912274 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg elacestrant QD
Number of subjects: 16
Study 32912274 — intervention group
Group type: EXPERIMENTAL
Intervention: Elacestrant (200 mg and 400 mg QD)
Number of subjects: 16
Study 35172277 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT + RT
Number of subjects: 50
Study 35172277 — intervention group
Group type: COMPARATOR
Intervention: MICT + RT
Number of subjects: 50
Study 33971441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol extraction combined with SERS
Number of subjects: 0
Study 32859100 — intervention group
Group type: COMPARATOR
Intervention: Pooled Intervention (Enhanced and Traditional)
Number of subjects: 116
Study 32859100 — intervention group
Group type: COMPARATOR
Intervention: Enhanced group
Number of subjects: 116
Study 34865095 — intervention group
Group type: EXPERIMENTAL
Intervention: Local oxygen‐ozone therapy plus medical treatment
Number of subjects: 25
Study 34865095 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment only
Number of subjects: 25
Study 33826027 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab plus EP
Number of subjects: 34
Study 33826027 — intervention group
Group type: COMPARATOR
Intervention: EP
Number of subjects: 34
Study 32200541 — intervention group
Group type: EXPERIMENTAL
Intervention: Totally intracorporeal neobladder techniques (Karolinska-modified Studer neobladder, USC-modified Studer neobladder, pyramid pouch, Y-pouch, vesica Ileale Padovana)
Number of subjects: 0
Study 36366308 — intervention group
Group type: EXPERIMENTAL
Intervention: FAKHRAVAC
Number of subjects: 435
Study 36366308 — intervention group
Group type: COMPARATOR
Intervention: BBIBP‐CorV
Number of subjects: 435
Study 34166055 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive distortions
Number of subjects: 150
Study 35665526 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy for binge-eating disorder (DBT-BED)
Number of subjects: 175
Study 35665526 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavior therapy (CBT+)
Number of subjects: 175
Study 34086514 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin, docetaxel, and capecitabine (CTX)
Number of subjects: 98
Study 34086514 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin, oxaliplatin, and capecitabine (EOX)
Number of subjects: 98
Study 33531359 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational UVR exposure (≥20 years)
Number of subjects: 38375
Study 33531359 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest cumulative UVR exposure
Number of subjects: 38375
Study 33531359 — intervention group
Group type: COMPARATOR
Intervention: Control group (no UVR exposure)
Number of subjects: 38375
Study 33068349 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at Sifeng (EX-UE 10), applied once every 2 days for a total of 4 times
Number of subjects: 80
Study 33068349 — intervention group
Group type: COMPARATOR
Intervention: Routine anti-infection and symptomatic and supportive treatment (Control Group)
Number of subjects: 80
Study 34930810 — intervention group
Group type: EXPERIMENTAL
Intervention: The Real Cost ads
Number of subjects: 623
Study 34930810 — intervention group
Group type: COMPARATOR
Intervention: Control videos
Number of subjects: 623
Study 34930810 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-item PME measure
Number of subjects: 623
Study 32740214 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionally ablative Er:YAG resurfacing, 3 treatments at monthly intervals
Number of subjects: 12
Study 35473348 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dosage of MKA plus lifestyle modifications
Number of subjects: 117
Study 35473348 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle modifications
Number of subjects: 117
Study 34187853 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of androgen deprivation therapy (ADT), 6 cycles of radium-223 q28 days, conventionally fractionated prostate radiotherapy (74 Gy) and simultaneous integrated boost to pelvic lymph nodes (60 Gy)
Number of subjects: 30
Study 36165862 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Bio-shield Superfood (NBS) 4.5 gr daily for 14 days
Number of subjects: 70
Study 36165862 — intervention group
Group type: COMPARATOR
Intervention: Placebo three times a day for 14 days
Number of subjects: 70
Study 34153543 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue photosensitizer (MBP)
Number of subjects: 40
Study 34153543 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% sodium ascorbate (AA)
Number of subjects: 40
Study 34153543 — intervention group
Group type: EXPERIMENTAL
Intervention: Er, Cr: YSGG laser (ECL)
Number of subjects: 40
Study 34153543 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 40
Study 35981113 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage and progressive relaxation exercises
Number of subjects: 97
Study 35981113 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 97
Study 35799145 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic surgery (SILS)
Number of subjects: 710
Study 35799145 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic surgery (CLS)
Number of subjects: 710
Study 34364385 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 621
Study 34364385 — intervention group
Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 621
Study 33109241 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC) session, cuff inflation and deflation (5 min each repeated 3 times) performed before the exercise by inflating cuffs to the non‐dominant leg and arm
Number of subjects: 20
Study 33109241 — intervention group
Group type: COMPARATOR
Intervention: Sham session, cuffs were inflated for a short period (1 min)
Number of subjects: 20
Study 33109241 — intervention group
Group type: COMPARATOR
Intervention: Control session, no cuffs were involved
Number of subjects: 20
Study 35500450 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 419
Study 35500450 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLB)
Number of subjects: 419
Study 35500450 — intervention group
Group type: COMPARATOR
Intervention: Clinical Management (CM)
Number of subjects: 419
Study 35500450 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Psychotherapy (GPT)
Number of subjects: 419
Study 33960065 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality glass showing ultrasound images of the foetus during labour
Number of subjects: 100
Study 33960065 — intervention group
Group type: COMPARATOR
Intervention: Routine procedures
Number of subjects: 100
Study 32033078 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced fat (2%) milk
Number of subjects: 30
Study 32033078 — intervention group
Group type: COMPARATOR
Intervention: Sugar-sweetened soda
Number of subjects: 30
Study 36191556 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% N2O/50% oxygen (N2O group)
Number of subjects: 44
Study 36191556 — intervention group
Group type: COMPARATOR
Intervention: 50% air/50% oxygen (placebo group)
Number of subjects: 44
Study 32073181 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal attire (tie and buttoned‐up white coat)
Number of subjects: 105
Study 32073181 — intervention group
Group type: COMPARATOR
Intervention: Casual attire (without tie or white coat)
Number of subjects: 105
Study 32073181 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall preference for physician
Number of subjects: 105
Study 36295512 — intervention group
Group type: EXPERIMENTAL
Intervention: Myrrh mouthwash
Number of subjects: 35
Study 36295512 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine gluconate mouthwash
Number of subjects: 35
Study 33663518 — intervention group
Group type: EXPERIMENTAL
Intervention: Care to Quit intervention (implementation of smoking cessation care models/pathways)
Number of subjects: 2160
Study 33663518 — intervention group
Group type: EXPERIMENTAL
Intervention: Care to Quit intervention
Number of subjects: 2160
Study 33663518 — intervention group
Group type: COMPARATOR
Intervention: Control condition (treatment as usual)
Number of subjects: 2160
Study 35978223 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-irradiated teeth (NoRad)
Number of subjects: 76
Study 35978223 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiated teeth with ER approach (RadER)
Number of subjects: 76
Study 35978223 — intervention group
Group type: COMPARATOR
Intervention: Irradiated teeth with SE approach (RadSE)
Number of subjects: 76
Study 34370912 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office whitening agent (Opalescence Boost 35%) with light irradiation
Number of subjects: 0
Study 34370912 — intervention group
Group type: COMPARATOR
Intervention: In-office whitening agent (Opalescence Boost 35%) without light irradiation
Number of subjects: 0
Study 36002025 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF) combined with SmartMind game
Number of subjects: 32
Study 36002025 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 32
Study 33090910 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body passive heating (42°C bath)
Number of subjects: 15
Study 33090910 — intervention group
Group type: COMPARATOR
Intervention: Dynamic lower body exercise (semi-recumbent stepping) at matched heart rate intensity (HRMATCHED)
Number of subjects: 15
Study 33090910 — intervention group
Group type: COMPARATOR
Intervention: Dynamic lower body exercise (semi-recumbent stepping) at higher intensity (53% V̇o2max)
Number of subjects: 15
Study 36203819 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam 0.2 mg kg‐1
Number of subjects: 104
Study 36203819 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline (control)
Number of subjects: 104
Study 34154433 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral nerve grafting and acidic fibroblast growth factor (aFGF) infusion
Number of subjects: 4
Study 34154433 — intervention group
Group type: COMPARATOR
Intervention: Spinal cord hemisection surgery (control)
Number of subjects: 4
Study 35555099 — intervention group
Group type: COMPARATOR
Intervention: High-Iron milk formula (HI) with 480 mg Fe/kg milk solid
Number of subjects: 24
Study 35555099 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Iron milk formula supplemented with inulin (HIP) at 6% of milk solid
Number of subjects: 24
Study 35555099 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Iron milk formula with inulin and Lactobacilus agilis (HIS)
Number of subjects: 24
Study 35555099 — intervention group
Group type: COMPARATOR
Intervention: Iron-adequate milk formula (AI) with 60 mg Fe/kg milk solid
Number of subjects: 24
Study 32184382 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 cm heel lift
Number of subjects: 14
Study 32885995 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 9007
Study 32885995 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 9007
Study 32885995 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-steroid anti-inflammatory drugs (NSAIDs)
Number of subjects: 9007
Study 32885995 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioids
Number of subjects: 9007
Study 33113886 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of spicule technique and nail brace with a polyethylene plastic strip
Number of subjects: 94
Study 33113886 — intervention group
Group type: COMPARATOR
Intervention: Spicule technique alone
Number of subjects: 94
Study 33113886 — intervention group
Group type: EXPERIMENTAL
Intervention: Nail brace technique
Number of subjects: 94
Study 36443282 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 40 mg daily for 1 week, then 20 mg daily for 1 week, then 10 mg daily for 1 week, plus NSAID for 3 weeks
Number of subjects: 40
Study 36082522 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 300
Study 33635385 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose alcohol (0.4 g kg−1)
Number of subjects: 0
Study 33635385 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose alcohol (0.8 g kg−1)
Number of subjects: 0
Study 33635385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32223849 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified pedometer-based Green Prescription
Number of subjects: 330
Study 32223849 — intervention group
Group type: COMPARATOR
Intervention: Standard time-based Green Prescription
Number of subjects: 330
Study 33179859 — intervention group
Group type: EXPERIMENTAL
Intervention: Down syndrome group (DS)
Number of subjects: 22
Study 33179859 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched by age and gender)
Number of subjects: 22
Study 34068000 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT_N0G5IJ
Number of subjects: 100
Study 34068000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32207984 — intervention group
Group type: EXPERIMENTAL
Intervention: Wendan decoction (WDD) administered three times daily for more than 1 month, initiated within 14 days of injury.
Number of subjects: 60
Study 32207984 — intervention group
Group type: COMPARATOR
Intervention: Conventional neurologic intensive care (Control group).
Number of subjects: 60
Study 35749349 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor control exercises
Number of subjects: 60
Study 35749349 — intervention group
Group type: COMPARATOR
Intervention: General exercises
Number of subjects: 60
Study 32554693 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy with TICI 2b-3 revascularization
Number of subjects: 70
Study 32977013 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive segmentectomy (MIS)
Number of subjects: 683
Study 32977013 — intervention group
Group type: COMPARATOR
Intervention: Open segmentectomy
Number of subjects: 683
Study 34911041 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling (DN) treatment
Number of subjects: 20
Study 34911041 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 32359367 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 46
Study 32359367 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 46
Study 35876008 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with magnesium, phosphate, omega 6 (linoleic acid calcium salt), and omega 7 (palmitoleic acid calcium salt)
Number of subjects: 532
Study 35876008 — intervention group
Group type: COMPARATOR
Intervention: Isotretinoin (13-cis retinoic acid)
Number of subjects: 532
Study 34242265 — intervention group
Group type: EXPERIMENTAL
Intervention: network-based approach for drug target indication expansion
Number of subjects: 15
Study 32561827 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrazine
Number of subjects: 0
Study 32561827 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribenuron-methyl
Number of subjects: 0
Study 32561827 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbicide doses less than the recommended field application concentration (RFAC)
Number of subjects: 0
Study 32561827 — intervention group
Group type: COMPARATOR
Intervention: Blank control
Number of subjects: 0
Study 34453952 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser peripheral iridotomy (LPI)
Number of subjects: 480
Study 34453952 — intervention group
Group type: COMPARATOR
Intervention: Control (fellow eye without LPI)
Number of subjects: 480
Study 34453952 — intervention group
Group type: EXPERIMENTAL
Intervention: LPI
Number of subjects: 480
Study 34453952 — intervention group
Group type: EXPERIMENTAL
Intervention: Older participants
Number of subjects: 480
Study 34453952 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline IOP
Number of subjects: 480
Study 33909773 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 10
Study 33909773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 32412097 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT plus agomelatine 50 mg/day (n = 48)
Number of subjects: 97
Study 32412097 — intervention group
Group type: COMPARATOR
Intervention: ECT plus placebo (n = 49)
Number of subjects: 97
Study 35641603 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum (CCH) injection
Number of subjects: 78
Study 35641603 — intervention group
Group type: COMPARATOR
Intervention: Limited fasciectomy (Surgery)
Number of subjects: 78
Study 33417876 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 200
Study 33417876 — intervention group
Group type: COMPARATOR
Intervention: Ramipril
Number of subjects: 200
Study 32407901 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime + roxithromycin
Number of subjects: 84
Study 32407901 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin + roxithromycin
Number of subjects: 84
Study 37441289 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US) guidance for interscalene block with 15 ml 0.5% bupivacaine and 5 ml 2% lignocaine
Number of subjects: 100
Study 37441289 — intervention group
Group type: COMPARATOR
Intervention: Nerve stimulator (NS) guidance for interscalene block with 15 ml 0.5% bupivacaine and 5 ml 2% lignocaine
Number of subjects: 100
Study 33998334 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer influence on handwashing behavior; 72% of children would wash hands if their friends were also washing hands.
Number of subjects: 106
Study 33998334 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of illness threat; >91% of children had low illness threat perception.
Number of subjects: 106
Study 33998334 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual proof of germs; 46% of children cited inability to see germs as a barrier to handwashing.
Number of subjects: 106
Study 33998334 — intervention group
Group type: EXPERIMENTAL
Intervention: Sources of information; Family, teachers, and peers were identified as the most important sources of information.
Number of subjects: 106
Study 36293867 — intervention group
Group type: EXPERIMENTAL
Intervention: KDL Active School Plan (KDL‐ASP)
Number of subjects: 596
Study 34495283 — intervention group
Group type: EXPERIMENTAL
Intervention: POINT group (opt-in narcotic treatment)
Number of subjects: 102
Study 34495283 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine narcotic prescriptions)
Number of subjects: 102
Study 36104820 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cognitive‐motor telerehabilitation programme
Number of subjects: 90
Study 36104820 — intervention group
Group type: COMPARATOR
Intervention: Only cognitive training
Number of subjects: 90
Study 36104820 — intervention group
Group type: COMPARATOR
Intervention: Only motor training
Number of subjects: 90
Study 33547218 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucroferric oxyhydroxide
Number of subjects: 160
Study 33547218 — intervention group
Group type: COMPARATOR
Intervention: Lanthanum carbonate
Number of subjects: 160
Study 33547218 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict phosphate target range (3.5-4.5 mg/dl)
Number of subjects: 160
Study 33547218 — intervention group
Group type: COMPARATOR
Intervention: Standard phosphate target range (5.0-6.0 mg/dl)
Number of subjects: 160
Study 33547218 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict phosphate control
Number of subjects: 160
Study 33547218 — intervention group
Group type: EXPERIMENTAL
Intervention: Older participants (aged 65-74 years)
Number of subjects: 160
Study 33547218 — intervention group
Group type: COMPARATOR
Intervention: Younger participants (aged 20-64 years)
Number of subjects: 160
Study 33420277 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Hz WBV intervention program
Number of subjects: 84
Study 33420277 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 Hz WBV intervention program
Number of subjects: 84
Study 33420277 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 84
Study 33371172 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular transitional nursing intervention
Number of subjects: 80
Study 35430119 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-5 embryo transfer (blastocyst stage)
Number of subjects: 134
Study 35430119 — intervention group
Group type: COMPARATOR
Intervention: Day-3 embryo transfer (cleavage stage)
Number of subjects: 134
Study 34070736 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based interventions
Number of subjects: 2202
Study 32138712 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiBIRTH intervention (evidence-based education of clinicians and women, appointment of opinion leaders, audit/peer review, joint discussions)
Number of subjects: 2002
Study 32138712 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 2002
Study 32138712 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiBIRTH intervention
Number of subjects: 2002
Study 32138712 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 2002
Study 32138712 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 2002
Study 35882541 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory syncytial virus (RSV)
Number of subjects: 931
Study 35882541 — intervention group
Group type: EXPERIMENTAL
Intervention: Human metapneumovirus (hMPV)
Number of subjects: 931
Study 35882541 — intervention group
Group type: EXPERIMENTAL
Intervention: Human rhinovirus/enterovirus (HRV/EV)
Number of subjects: 931
Study 35882541 — intervention group
Group type: EXPERIMENTAL
Intervention: Parainfluenza
Number of subjects: 931
Study 35882541 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical bacterial pathogens
Number of subjects: 931
Study 33040439 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy (esomeprazole 20 mg and amoxicillin 750 mg four times daily)
Number of subjects: 760
Study 33040439 — intervention group
Group type: COMPARATOR
Intervention: Triple plus bismuth (TPB) therapy (esomeprazole 20 mg, amoxicillin 1000 mg, clarithromycin 500 mg, and bismuth potassium citrate 220 mg twice daily)
Number of subjects: 760
Study 33040439 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy
Number of subjects: 760
Study 33040439 — intervention group
Group type: COMPARATOR
Intervention: TPB therapy
Number of subjects: 760